6Fulsome AR.Epidemiology of fibrinogen[J].Eur Heart J,2002,23(Suppl A):21-26.
7Alberti KG,Zimmet PZ. Defnition,diagnosis and classification of diabetes mellitus and its complications. Part Ⅰ:diagnosis and classification of diabetes mellitus provisional report of a WHO consulation. Diabet Med, 1998, 15:535.
8McLaren M, Elhadd TA, Greene SA, et al. Elevated plasma vascular endothelial cell growth factor and thrombomodulin in juvenile diabetic patients. Clin Appl Thromb Hemost, 1999,5 ( 1 ) : 21-24.
9Boffa MC, Karochkine M, Berard M. Plasma thrombomodulin as a marker of endothelium damage. Nouv Rev Fr Hematol,1991,33(6):529-530.
10Blann AD, Lip GY. Hypothesis: is soluble P-selectin a new marker of platelet activation? Atherosclerosis, 1997,10,128(2) : 135-138.
9Tatasciore A, Renda G, Zimarino M, et al. Awake systolic blood pressure variability correlates with target-organ damage in hypertensive subjects. Hypertension, 2007,50:325-332.
10Masahiro K, Takayoshi O, Hirohito M, et al. Day-by-day vari- ability of blood pressure and heart rate at home as a novel predictor of prognosis. Hypertension, 2008,52 : 1045-1050.
